ArticleThe European respiratory journal2025
Reply: Tofacitinib is a step forward for management of patients with interstitial lung disease associated with anti-MDA5-positive dermatomyositis.
Wanlong Wu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.